Mitra Ramgopal
Stock Analyst at Sidoti & Co.
(3.02)
# 1,246
Out of 4,853 analysts
21
Total ratings
73.33%
Success rate
33.14%
Average return
Main Sectors:
Stocks Rated by Mitra Ramgopal
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| BCPC Balchem | Upgrades: Buy | $175 | $166.28 | +5.24% | 6 | Feb 22, 2022 | |
| TRNS Transcat | Upgrades: Buy | $60 | $79.91 | -24.92% | 2 | May 19, 2021 | |
| AMN AMN Healthcare Services | Maintains: Buy | $72 → $70 | $20.05 | +249.13% | 5 | Jun 16, 2020 | |
| ADUS Addus HomeCare | Maintains: Buy | $96 → $115 | $112.01 | +2.67% | 4 | Jun 1, 2020 | |
| USPH U.S. Physical Therapy | Maintains: Buy | $128 → $80 | $74.77 | +6.99% | 1 | Mar 27, 2020 | |
| BEAT HeartBeam | Maintains: Buy | $81 → $75 | $1.68 | +4,364.29% | 3 | Feb 27, 2020 |
Balchem
Feb 22, 2022
Upgrades: Buy
Price Target: $175
Current: $166.28
Upside: +5.24%
Transcat
May 19, 2021
Upgrades: Buy
Price Target: $60
Current: $79.91
Upside: -24.92%
AMN Healthcare Services
Jun 16, 2020
Maintains: Buy
Price Target: $72 → $70
Current: $20.05
Upside: +249.13%
Addus HomeCare
Jun 1, 2020
Maintains: Buy
Price Target: $96 → $115
Current: $112.01
Upside: +2.67%
U.S. Physical Therapy
Mar 27, 2020
Maintains: Buy
Price Target: $128 → $80
Current: $74.77
Upside: +6.99%
HeartBeam
Feb 27, 2020
Maintains: Buy
Price Target: $81 → $75
Current: $1.68
Upside: +4,364.29%